Page results
-
This booklet explains what you can expect during recovery from your autologous stem cell transplant.
-
Critical care incorporates general adult intensive care, high-dependency, the Post-Anaesthetic Care Unit (PACU), critical care outreach and the Critical Care Follow-up Clinic.
-
Evidence shows that in selected cases open fetal surgery to close the spina bifida defect improves baby outcomes compared to surgery after birth.
-
The Interventional Oncology Service (IOS) at University College London Hospital (UCLH) is committed to improving the experience and outcomes for patients with cancer through cutting edge image guided interventions.
-
The oesophageal and stomach surgery service works very closely with the specialist Upper Gastrointestinal (GI) service, gastroenterology, nutrition, oncology and radiology departments at UCLH. It comprises UCLH-based and Barts Health-based surgeons.
-
Our andrology unit manages patients with andrological conditions including male sterilisation and infertility service, and other disorders of the penis or male genitalia.
-
We offer management of kidney stone disease, including in-house lithotripsy, rigid ureteroscopy, flexible ureterorenoscopy and laser disintegration of stones in ureters and kidneys and percutaneous nephrolithotomy.
-
The COVID Medicines Delivery Unit (CMDU gives new COVID-19 treatments for patients at highest risk in the community from the NCL sector. These treatments involve intravenous infustion of neutralising monoclonal antibodies (nMABs) or oral antiviral treatments, which are given to high-risk patients who have had a positive PCR test.
-
Oropharyngeal cancer is a type of cancer that affects the part of the throat at the back of the mouth.
-
This page is for patients who are receiving radiotherapy to the bladder.
File results
-
FOI/2023/0310 - Biologic treatment/ medicines in dermatology
-
FOI/2023/0313 - Consent, confidentiality and information sharing in mental healthcare and suicide
-
FOI/2023/0315 - Menopause Lead at the Trust
-
FOI/2023/0319 - Multiple Sclerosis (MS) treatment/ medication for any diseases
-
FOI/2023/0323 - Medications/ treatment for dermatology and respiratory medicine
-
FOI/2023/0336 - Number of pagers currently in use at the Trust
-
FOI/2023/0342 - Self-administration of medication policies
-
FOI/2023/0337 - Trac systems e-recruitment software used at the Trust
-
FOI/2023/0304 - Chronic lymphocytic leukaemia treatments
-
FOI/2023/0330 - Outsourced/ in-house occupational health provisions